PC

Pranesh Chandrakant Hastak

Active Director Director DIN 02999339
DIN 02999339 First appointment Jun 2013 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Pranesh Chandrakant Hastak

Data last updated:

Pranesh Chandrakant Hastak is a Director at Biovascular Devices Research Limited (since 2013). The company operates in Healthcare.

DIN 02999339
Primary Designation Director
Industry Healthcare
First Appointment 22 Jun 2013
Oldest Company Age 31 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biovascular Devices Research Limited U73100GJ1995PLC024048
Director22 Jun 20131995Active

Board colleagues of Pranesh Chandrakant Hastak

Directorship timeline

Open interactive timeline →
Biovascular Devices Research Limited
Premium access

Shareholding and investment profile for Pranesh Chandrakant Hastak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pranesh Chandrakant Hastak

Pranesh Chandrakant Hastak currently holds 1 directorship: Biovascular Devices Research Limited (Director, since 22 Jun 2013).

Pranesh Chandrakant Hastak was first appointed on 22 Jun 2013 as Director at Biovascular Devices Research Limited.

The current boards of Pranesh Chandrakant Hastak's companies include Kalpesh M Shah (Biovascular Devices Research Limited), Prashantbhai Chandrakant Hastak (Biovascular Devices Research Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available